Buy Cadila Healthcare; target of Rs 550: Motilal Oswal
Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 550 in its research report dated February 06, 2021.12-02-2021
Buy Cadila Healthcare; target of Rs 550: Motilal Oswal
Motilal Oswal is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 550 in its research report dated February 06, 2021.Buy Cadila Healthcare; target of Rs 555: ICICI Direct
ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 555 in its research report dated February 06, 2021.CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
The Newspaper Publication of Notice of loss of share certificate of the Company, published in the Financial ExpressZydus Cadila has more orders for Covid-19 vaccine than it can make: Report
The company plans to set up a plant to produce 120 million doses of ZyCoV-DCADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
the newspaper cutting dated February 6, 2021 with regard to unaudited financial results of the Company for the quarter / nine months ended on December 31, 2020 published in the Financial ExpressEarnings Call for Q3FY21 of Cadila Healthcare
Conference Call with Cadila Healthcare Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.Cadila standalone Q3 net falls 35% to 140 crore
Cadila Healthcare Ltd on Friday reported a standalone net profit of 140 crore for the quarter ended December 2020, down 34.6 per cent against 2CADILA HEALTHCARE LTD. - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate / issue of duplicate share certificate under regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Change in Directorate
Re appointment of Mr. Apurva Diwanji for the second term of five consecutive years.CADILA HEALTHCARE LTD. - 532321 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter / Nine Months Ended On December 31, 2020
Unaudited financial results (standalone and consolidated) for the quarter / nine months ended on December 31, 2020